Skip to main content

Advertisement

SpringerLink
Log in

Radical prostatectomy versus high dose permanent prostate brachytherapy using iodine-125 seeds for patients with high risk prostate cancer: a matched cohort analysis

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Objective

To compare the biochemical outcomes reported after radical prostatectomy (RP) versus high dose permanent prostate brachytherapy (HDPPB) using iodine-125 seeds in the treatment of matched high risk prostate cancer (HiPCa).

Methods

In this retrospective review, 55 HiPCa patients treated between March 2006 and August 2011, who underwent HDPPB using iodine-125 seeds combined with external beam radiation therapy (EBRT) or androgen deprivation therapy (ADT), were compared with 55 HiPCa patients who underwent RP. Patients were matched for age, prostate-specific antigen (PSA), clinical stage, and Gleason scores. The biochemical outcomes after HDPPB and RP were compared via Kaplan–Meier analysis.

Results

Of the 110 patients analyzed, the mean ages, PSA, and Gleason biopsy scores were similar between the two cohorts. Among patients who underwent HDPPB, 20 patients (36.4 %) had received adjuvant EBRT. Of this subsample, most patients (98.2 %) had received adjuvant ADT for 3 months. Among patients with RP, 20 patients (36.4 %) had received adjuvant EBRT, whereas 28 patients had received adjuvant ADT. The mean implanted seed numbers were 92.8, the mean D90 was 218.7 Gy, and the mean V100 was 96.1 % after HDPPB. With regard to oncological outcomes, biochemical disease-free survival rates were similar between the two cohorts (82.6 vs. 81.1 %, p = 0.982). Urethrorectal fistula developed in one patient with HDPPB.

Conclusion

RP and HDPPB, using iodine-125 seeds with combined treatment modalities, exhibited similar biochemical recurrence-free survival rates among HiPCa patients. Further prospective studies with greater sample sizes and longer follow-up periods are needed to validate these results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280(11):969–974

    Article  PubMed  Google Scholar 

  2. Stokes SH (2000) Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation. Int J Radiat Oncol Biol Phys 47(1):129–136

    Article  PubMed  CAS  Google Scholar 

  3. Kupelian PA, Potters L, Khuntia D, Ciezki JP, Reddy CA, Reuther AM, Carlson TP, Klein EA (2004) Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer. Int J Radiat Oncol Biol Phys 58(1):25–33

    Article  PubMed  Google Scholar 

  4. Litwin MS, Gore JL, Kwan L, Brandeis JM, Lee SP, Withers HR, Reiter RE (2007) Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 109(11):2239–2247. doi:10.1002/cncr.22676

    Article  PubMed  Google Scholar 

  5. Giberti C, Chiono L, Gallo F, Schenone M, Gastaldi E (2009) Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study. World J Urol 27(5):607–612. doi:10.1007/s00345-009-0418-9

    Article  PubMed  CAS  Google Scholar 

  6. Quaranta BP, Marks LB, Anscher MS (2004) Comparing radical prostatectomy and brachytherapy for localized prostate cancer. Oncology (Williston Park) 18(10):1289–1302 (discussion 1302–1284, 1309)

    Google Scholar 

  7. Koontz BF, Chino J, Lee WR, Hahn CA, Buckley N, Huang S, Kim J, Reagan R, Joyner R, Anscher MS (2009) Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer. Brachytherapy 8(2):191–196

    Article  PubMed  Google Scholar 

  8. Fletcher SG, Mills SE, Smolkin ME, Theodorescu D (2006) Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 66(4):1092–1099

    Article  PubMed  Google Scholar 

  9. Zelefsky MJ, Hollister T, Raben A, Matthews S, Wallner KE (2000) Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 47(5):1261–1266

    Article  PubMed  CAS  Google Scholar 

  10. Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Mattelaer J, Lopez Torecilla J, Pfeffer JR, Lino Cutajar C, Zurlo A, Pierart M (2002) Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360(9327):103–106

    Article  PubMed  CAS  Google Scholar 

  11. Roach M 3rd, DeSilvio M, Lawton C, Uhl V, Machtay M, Seider MJ, Rotman M, Jones C, Asbell SO, Valicenti RK, Han S, Thomas CR Jr, Shipley WS (2003) Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 21(10):1904–1911. doi:10.1200/JCO.2003.05.004

    Article  PubMed  Google Scholar 

  12. Sharkey J, Cantor A, Solc Z, Huff W, Chovnick SD, Behar RJ, Perez R, Otheguy J, Rabinowitz R (2002) Brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer. Curr Urol Rep 3(3):250–257

    Article  PubMed  Google Scholar 

  13. Yu Y, Anderson LL, Li Z, Mellenberg DE, Nath R, Schell MC, Waterman FM, Wu A, Blasko JC (1999) Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64. Med Phys 26(10):2054–2076

    Article  PubMed  CAS  Google Scholar 

  14. Salembier C, Lavagnini P, Nickers P, Mangili P, Rijnders A, Polo A, Venselaar J, Hoskin P (2007) Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. Radiother Oncol 83(1):3–10

    Article  PubMed  Google Scholar 

  15. Walsh PC (1998) Anatomic radical prostatectomy: evolution of the surgical technique. J Urol 160(6 Pt 2):2418–2424

    PubMed  CAS  Google Scholar 

  16. Merrick GS, Grimm PD, Sylvester J, Blasko JC, Butler WM, Allen ZA, Chaudhry UU, Mazza A, Sitter M (2007) Initial analysis of Pro-Qura: a multi-institutional database of prostate brachytherapy dosimetry. Brachytherapy 6(1):9–15

    Article  PubMed  Google Scholar 

  17. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, Zattoni F (2008) EAU guidelines on prostate cancer. Eur Urol 53(1):68–80

    Article  PubMed  Google Scholar 

  18. Roach M 3rd, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, Sandler H (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65(4):965–974

    Article  PubMed  Google Scholar 

  19. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213

    Article  PubMed  Google Scholar 

  20. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341–1346

    Article  PubMed  CAS  Google Scholar 

  21. Walsh PC (2000) Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. J Urol 163(6):1802–1807

    Article  PubMed  CAS  Google Scholar 

  22. Westover K, Chen MH, Moul J, Robertson C, Polascik T, Dosoretz D, Katin M, Salenius S, D’Amico AV (2012) Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer. BJU Int. doi:10.1111/j.1464-410X.2012.11012.x

    PubMed  Google Scholar 

  23. Grimm P, Billiet I, Bostwick D, Dicker AP, Frank S, Immerzeel J, Keyes M, Kupelian P, Lee WR, Machtens S, Mayadev J, Moran BJ, Merrick G, Millar J, Roach M, Stock R, Shinohara K, Scholz M, Weber E, Zietman A, Zelefsky M, Wong J, Wentworth S, Vera R, Langley S (2012) Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int 109(Suppl 1):22–29. doi:10.1111/j.1464-410X.2011.10827.x

    Google Scholar 

  24. Lederman GS, Cavanagh W, Albert PS, Israeli R, Lessing J, Savino M, Volpicella F (2001) Retrospective stratification of a consecutive cohort of prostate cancer patients treated with a combined regimen of external-beam radiotherapy and brachytherapy. Int J Radiat Oncol Biol Phys 49(5):1297–1303

    Article  PubMed  CAS  Google Scholar 

  25. Ho AY, Burri RJ, Cesaretti JA, Stone NN, Stock RG (2009) Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 75(1):16–22

    Article  PubMed  CAS  Google Scholar 

  26. Buron C, Le Vu B, Cosset JM, Pommier P, Peiffert D, Delannes M, Flam T, Guerif S, Salem N, Chauveinc L, Livartowski A (2007) Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study. Int J Radiat Oncol Biol Phys 67(3):812–822

    Article  PubMed  Google Scholar 

  27. Crook JM, Gomez-Iturriaga A, Wallace K, Ma C, Fung S, Alibhai S, Jewett M, Fleshner N (2011) Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial. J Clin Oncol 29(4):362–368

    Article  PubMed  Google Scholar 

  28. Borchers H, Kirschner-Hermanns R, Brehmer B, Tietze L, Reineke T, Pinkawa M, Eble MJ, Jakse G (2004) Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results. BJU Int 94(6):805–811

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no conflicts of interest with any institutions or products. No financial support was received by any author.

Author information

Authors and Affiliations

  1. Department of Urology, CHA Bundang Medical Center, CHA University, 351 yatap-dong, Bundang-gu, Seongnam-si, 463-712, Korea

    Dong Soo Park, In Hyuck Gong, Don Kyung Choi, Jin Ho Hwang & Jong Jin Oh

  2. Department of Radiation Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Korea

    Hyun Soo Shin

  3. CHA Cancer Institute, CHA University, Seoul, Korea

    Jong Jin Oh

Authors
  1. Dong Soo Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. In Hyuck Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Don Kyung Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jin Ho Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hyun Soo Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jong Jin Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jong Jin Oh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, D.S., Gong, I.H., Choi, D.K. et al. Radical prostatectomy versus high dose permanent prostate brachytherapy using iodine-125 seeds for patients with high risk prostate cancer: a matched cohort analysis. World J Urol 31, 1511–1517 (2013). https://doi.org/10.1007/s00345-013-1086-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-013-1086-3

Keywords

Search

Navigation